Pfizer Ends Clinical Trials For COVID-19 Vaccine With 95% Efficacy
Pfizer had ended its clinical trials for COVID-19 vaccine with 95% efficacy. Pfizer Inc. on Wednesday said that the final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective Also, Pfizer said that it had the required two months of safety data and will apply for an emergency use authorization … Read more